Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SLDB | Common Stock | Options Exercise | +11.3K | +564.48% | 13.2K | Jan 9, 2024 | Direct | F1, F2 | ||
transaction | SLDB | Common Stock | Sale | -$32.3K | -3.94K | -29.71% | $8.20 | 9.31K | Jan 9, 2024 | Direct | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SLDB | Restricted Stock Units | Options Exercise | $0 | -11.3K | -25% | $0.00 | 33.8K | Jan 9, 2024 | Common Stock | 11.3K | Direct | F1, F4 |
Id | Content |
---|---|
F1 | Restricted stock units convert to common stock on a one-for-one basis. |
F2 | Includes 1,993 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023. |
F3 | This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Mr. Tan. |
F4 | The restricted stock units were granted on January 9, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. |